Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Rolf Wachter Added: 4 years ago
In this video, Prof Rolf Wacehtr (Leipzing University Hospital, Leipzig, DE) presents a comprehensive review of TRANSITION-CHF. Filmed on site at ESC 2019 by Radcliffe Cardiology. Videography: Mike Knight & Tom Green This interview is a component of a wider Radcliffe Education programme entitled,'Review of emerging ARNI data in HFrEF'. Certified accreditation of the full programme is pending… View more
Author(s): David Morrow Added: 4 years ago
In this video, Prof David A Morrow, Professor of Medicine and Cardiology from the Harvard Medical School, Boston, MA, US, discusses the emerging data on utilising Angiotensin Receptor-Neprilysin Inhibitor (ARNI) therapy in complex patients. Filmed on site at ESC 2019 by Radcliffe Cardiology. This interview is a component of a wider Radcliffe Education programme entitled,'Review of emerging… View more
Author(s): Akshay S Desai Added: 4 years ago
In this video, Prof Akshay Desai (Harvard Medical School, MA, US) presents a comprehensive review of EVALUATE-HF. Filmed on site at ESC 2019 by Radcliffe Cardiology. Interviewer: Carrie Barclay Videography: Mike Knight & Tom Green This interview is a component of a wider Radcliffe Education programme entitled,'Review of emerging ARNI data in HFrEF'. Certified accreditation of the full… View more
Author(s): Carolyn Lam , Giuseppe Rosano Added: 7 months ago
In this short video series, recorded at ESC 2023 in Amsterdam,Prof Carolyn Lam(National Heart Centre Singapore, SG) and Prof Giuseppe Rosano(St George’s University Medical School of London, UK) discuss the latest heart failure guideline updates and what this means for clinical practice. Since the publication of the 2021 ESC Guidelines, several randomised controlled trials have provided… View more
Author(s): James L Januzzi Added: 4 years ago
In this video, Prof James Januzzi (Harvard Medical School, MA, US) presents a comprehensive review of PROVE-HF - Interpreting potential mechanistic data related to the clinical benefit of ARNI therapy including imaging and biomarker data. Filmed on site at ESC 2019 by Radcliffe Cardiology. This interview is a component of a wider Radcliffe Education programme entitled,'Review of emerging ARNI… View more
Author(s): Ankur Kalra , Sukhjinder Nijjer Added: 4 months ago
In this week's Parallax, Dr Ankur Kalra welcomes back Dr Sukhjinder Nijjer for their much-anticipated annual review of advancements in cardiovascular medicine that defined the year 2023.Dr Nijjer, a Consultant Cardiologist in the UK, serves as the President of the Royal Society of Medicine and is an Honorary Senior Clinical Lecturer at Imperial College London.Drs Kalra and Nijjer share their… View more
Author(s): Ankur Kalra , Sukhjinder Nijjer Added: 4 months ago
In this week's Parallax podcast, Dr Ankur Kalra welcomes back Dr Sukhjinder Nijjer for their much-anticipated annual review of advancements in cardiovascular medicine that defined the year 2023.Dr Nijjer, a Consultant Cardiologist in the UK, serves as the President of the Royal Society of Medicine and is an Honorary Senior Clinical Lecturer at Imperial College London.Drs Kalra and Nijjer share… View more
Author(s): Jacqueline H Morris , Leway Chen Added: 3 years ago
Congestive heart failure (CHF) is a progressive cardiovascular disease with significant morbidity and mortality that affects an increasing amount of people worldwide. There are approximately 6.5 million people in the US, more than 14 million people in Europe, and 26 million people worldwide who are living with heart failure, and the prevalence continues to grow.1–3 In the US alone, there were 960… View more